Medical technology

Insights on the Neurostimulation Devices Global Market to 2026 - Rise in Number of People Suffering from Hearing Loss is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, September 6, 2021
Medical Devices, Health, Medical technology, Branches of biology, Health sciences, Medical devices, Audiology, Otology, Neurotechnology, Neuroprosthetics, Neurostimulation, Implant, Hearing loss, Hearing aid

Neurostimulation is used as a key element in neural prosthetics for hearing aids, artificial vision, artificial limbs, brain-machine interfaces, etc.

Key Points: 
  • Neurostimulation is used as a key element in neural prosthetics for hearing aids, artificial vision, artificial limbs, brain-machine interfaces, etc.
  • the growth in the neurostimulation devices market may be attributed to the increasing prevalence of chronic neuromuscular disorder and the rising adoption of these devices by the physicians.
  • However, stringent regulations of the neurostimulation devices and lack of skilled professionals for performing the surgeries might restrain the market growth during the given time frame.
  • The market is expected to surge in the coming years, due to the rise in the number of people, suffering from hearing loss and other related concerns.

Global Smart Syringes Market 2021: Advance Production of Smart Syringes Underway to Meet Growing Needs of COVID-19 Vaccine Roll-out - ResearchAndMarkets.com

Retrieved on: 
Monday, September 6, 2021
Health, Medical Supplies, Medical Devices, Medical equipment, Medical technology, Drug paraphernalia, Medicine, Health sciences, Syringe, Safety syringe, Needlestick injury, BD, Injection, Blood-borne disease, Hypodermic needle

The global smart syringes market growth is registered on account of the growing prevalence of target diseases, the rise in number of vaccinations, and the growth of the geriatric population.

Key Points: 
  • The global smart syringes market growth is registered on account of the growing prevalence of target diseases, the rise in number of vaccinations, and the growth of the geriatric population.
  • The high cost of smart syringes, especially passive safety syringes as well as lack of awareness in developing nations, and alternative drug delivery methods are expected to hinder the global smart syringes market growth.
  • The Global Smart Syringes Market is segmented into product type such as Auto-disable syringes, Active safety syringes, and Passive safety syringes, by application such as Vaccination, Blood Specimen Collection, and Drug delivery.
  • North America is expected to hold highest market share in the global smart syringe market followed by Europe, and Asia-Pacific.

Thought Technology Ltd. Enters Co-Marketing Agreement with NeuroTracker

Retrieved on: 
Wednesday, August 4, 2021
Neuropsychology, Branches of biology, Cognitive science, Neuroscience, Cognition, ISO 13485, Medical equipment, Medical technology, Brain training, Situation awareness, Psychophysiology

Always on the lookout for new markets for their products, they just entered a co-marketing agreement with NeuroTracker , makers of the NeuroTracker cognitive training system.

Key Points: 
  • Always on the lookout for new markets for their products, they just entered a co-marketing agreement with NeuroTracker , makers of the NeuroTracker cognitive training system.
  • Training with NeuroTracker enhances situational awareness, attention, executive function, and cognitive stamina, which helps people of all ages increase brain performance.
  • Thought Technology Sales and Marketing Director, Helen Mavros said, "There is a great synergy between our line of psychophysiological assessment and training instruments and the NeuroTracker cognitive training system.
  • Constantly striving to improve the quality of the products and services, Thought Technology has obtained, and maintains, ISO 13485, and CE certification for the organization and products.

Kestra Medical Technologies Receives FDA Premarket Approval for ASSURE Wearable Cardioverter Defibrillator (WCD)

Retrieved on: 
Tuesday, August 3, 2021
FDA, Health, Cardiology, Medical devices, Cardiac electrophysiology, Branches of biology, Medical technology, Human–computer interaction, Cardiology, Medical equipment, Wearable cardioverter defibrillator, WCD, Automated external defibrillator, Medical device, Wearable technology, Cardiac arrest

Kestra Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE Wearable Cardioverter Defibrillator (WCD) system.

Key Points: 
  • Kestra Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE Wearable Cardioverter Defibrillator (WCD) system.
  • The ASSURE WCD system represents the next generation of monitoring and therapy to protect patients at risk of Sudden Cardiac Death (SCD).
  • The system includes a modern, comfortable wearable device with integrated sensors, a cardiac rhythm monitor and miniaturized automated external defibrillator.
  • Kestra Medical Technologies, Inc. is a privately held wearable medical device and digital healthcare company that protects cardiac patients with diagnostic monitoring and therapeutic technologies that are intuitive, intelligent, and mobile.

Practice EHR Reveals New Brand Image - The ONE - Including Redesigned Logo and Website

Retrieved on: 
Tuesday, August 3, 2021
Electronic health records, Health, Information technology, Medical technology

PLANO, Texas, Aug. 3, 2021 /PRNewswire-PRWeb/ -- Practice EHR , a leading provider of simple, cloud-based, cost-effective healthcare solutions, announced today the launch of its new brand, including a redesigned logo and website.

Key Points: 
  • PLANO, Texas, Aug. 3, 2021 /PRNewswire-PRWeb/ -- Practice EHR , a leading provider of simple, cloud-based, cost-effective healthcare solutions, announced today the launch of its new brand, including a redesigned logo and website.
  • The company's new brand identity The ONE represents that Practice EHR is the ideal solution, providing one seamless workflow for managing all major tasks in the medical practice.
  • Compared to other software, Practice EHR is easy to use, no matter the technical comfort level of the user.
  • The newly redesigned corporate website was released to reflect the new brand identity and showcase the company's software solutions, including Practice EHR Enterprise , its newly launched practice management software for enterprise organizations.

SI-BONE, Inc. Announces Anthem, Inc. Adopts Coverage Guidelines for Sacroiliac Joint Fusion Exclusive to the Triangular iFuse Implant System® for Its More Than 40 Million Members

Retrieved on: 
Monday, August 2, 2021
Prosthetics, Anatomy, Pelvis, Medical specialties, Medical technology, Biomedical engineering, Implant, Tissue engineering, Sacroiliac joint

Anthem has adopted coverage guidelines from AIM Specialty Health, a subsidiary specialty benefit management company with medical necessity guidelines that support minimally invasive SI joint fusion only when iFuse implants (titanium triangular implants) are used.

Key Points: 
  • Anthem has adopted coverage guidelines from AIM Specialty Health, a subsidiary specialty benefit management company with medical necessity guidelines that support minimally invasive SI joint fusion only when iFuse implants (titanium triangular implants) are used.
  • The new policy provides coverage for chronic sacroiliac joint pain and functional impairment, provided certain criteria are met, resulting in virtually universal coverage for the iFuse Implant System.
  • Since then, more than 2,400 surgeons have performed a combined total of more than 55,000 SI joint fusion procedures.
  • SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc. 2021 SI-BONE, Inc. All Rights Reserved.

Premom Announces Launch of New Membership Program Aimed to Help Women Achieve Pregnancy Faster

Retrieved on: 
Friday, July 30, 2021
Women's health, Fertility awareness, Medical technology, Fertility, Ava, Mobile applications

Paid tiers offer additional benefits, like receiving Premom’s sister brand Easy@Home -- the best-selling ovulation predictor kit, three physician-designed and interpreted cycle reports, personalized content and fertility expert services -- like getting questions answered by a qualified expert, and viewing of the fertility app’s constantly updated Q&A library of accurate answers. All membership tiers are available on iOS and Android devices in the Premom Ovulation and Period Tracker app. Currently only available in the USA but will be released soon to other countries.

Key Points: 
  • Each tier was strategically designed with collaborations from leading fertility experts to better assist women at different stages in their fertility journeys.
  • The Bronze tier, free to all Premom app users, includes Premoms pioneer 9-Cycle Money-Back Guarantee program, which has proven to show a 377% higher pregnancy success rate among those who followed the guidelines of the program.
  • All membership tiers are available on iOS and Android devices in the Premom Ovulation and Period Tracker app.
  • "For years, we have been dedicated to developing a successful path for women to achieve pregnancy faster.

Medical Device Contract Manufacturing Market by Device Type, Class of Device, Services and Region - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 29, 2021
Medical devices, Health, Medical device, Medical technology, Medical devices, Food and Drug Administration, Wi, Inc., Single-use medical devices

Based on the class of device, the medical device contract manufacturing market is segmented into Class I, Class II, and Class III medical devices.

Key Points: 
  • Based on the class of device, the medical device contract manufacturing market is segmented into Class I, Class II, and Class III medical devices.
  • In 2020, the Class II medical devices segment is projected to grow at the highest CAGR in the medical device contract manufacturing market.
  • Based on service, the medical device contract manufacturing market is segmented into device development and manufacturing services, quality management services, packaging and assembly services, and other services.
  • The increasing adoption of contract manufacturing services in the medical device industry, growth in the medical devices market (especially in the single-use disposable medical devices market), and improving device development and manufacturing capabilities are the major factors responsible for the large share of this segment.

Implicity to Exhibit its Comprehensive Portfolio and Present New Scientific Data at HRS Annual Scientific Sessions

Retrieved on: 
Thursday, July 29, 2021
American brands, Companies, Medical technology, Industry economics), Cardiac electrophysiology, Biotronik, Medtronic, Microport, Microport, Boston Scientific

CAMBRIDGE, Mass., July 29, 2021 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, today announced its newest technology will be featured at Heart Rhythm 2021 (HRS) and that the company will present scientific data at the annual Scientific Sessions.

Key Points: 
  • CAMBRIDGE, Mass., July 29, 2021 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, today announced its newest technology will be featured at Heart Rhythm 2021 (HRS) and that the company will present scientific data at the annual Scientific Sessions.
  • Implicity's newest technology is presented in an abstract that was selected by the Scientific Committee for an e-Poster presentation.
  • The Implicity platform is medical decision aid software that collects and unifies data from all cardiac implants manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort).
  • Implicity covers more than 40,000 patients in over 70 medical facilities across Europe and the United States.

Electroceuticals/Bioelectric Medicine Markets, 2026 - Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators, Ischemia, Epilepsy, Implantable, Noninvasive - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 28, 2021
General Health, Science, Health, Research, Branches of biology, Medical technology, Biology, Medical devices, Neurotechnology, Biomedical engineering, Prosthetics, Cybernetics, Neuromodulation, Neurostimulation, Implant, Stimulator

The "Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • On the other hand, the high cost of electroceutical devices and the requirement of high capital investments are the major factors hampering the growth of this market.
  • In 2020, the cochlear implants segment accounted for the highest growth rate in the electroceuticals market.
  • The global electroceuticals market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.